ZA884835B - Treatment of cerebral disorders - Google Patents

Treatment of cerebral disorders

Info

Publication number
ZA884835B
ZA884835B ZA884835A ZA884835A ZA884835B ZA 884835 B ZA884835 B ZA 884835B ZA 884835 A ZA884835 A ZA 884835A ZA 884835 A ZA884835 A ZA 884835A ZA 884835 B ZA884835 B ZA 884835B
Authority
ZA
South Africa
Prior art keywords
treatment
cerebral disorders
cerebral
disorders
Prior art date
Application number
ZA884835A
Other languages
English (en)
Inventor
David Frederick Horrobin
Frederick Horrobin David
Frank Corrigan
Corrigan Frank
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA884835B publication Critical patent/ZA884835B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA884835A 1987-07-07 1988-07-06 Treatment of cerebral disorders ZA884835B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878715914A GB8715914D0 (en) 1987-07-07 1987-07-07 Treatment of cerabral disorders

Publications (1)

Publication Number Publication Date
ZA884835B true ZA884835B (en) 1989-03-29

Family

ID=10620197

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884835A ZA884835B (en) 1987-07-07 1988-07-06 Treatment of cerebral disorders

Country Status (5)

Country Link
EP (1) EP0298644A3 (ja)
JP (1) JPH01156922A (ja)
AU (1) AU608865B2 (ja)
GB (1) GB8715914D0 (ja)
ZA (1) ZA884835B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
IL106484A (en) * 1992-07-31 1998-08-16 Lai John Methods of drug treatment and anesthesia and their use
AU674151B2 (en) * 1992-07-31 1996-12-12 John Lai Therapeutic methods using caesium ions
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182754A (en) * 1976-10-14 1980-01-08 Bonadio George A H Oral ingestion of indium
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
GB8425006D0 (en) * 1984-10-03 1984-11-07 Efamol Ltd Composition of copper/fatty acids

Also Published As

Publication number Publication date
EP0298644A3 (en) 1990-11-14
JPH01156922A (ja) 1989-06-20
AU1875688A (en) 1989-01-12
EP0298644A2 (en) 1989-01-11
AU608865B2 (en) 1991-04-18
GB8715914D0 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
ZA87247B (en) Treatment of skin disorders
GB8718708D0 (en) Apparatus for treatment of spinal disorders
IL83925A0 (en) Compositions for treatment of skin disorders
GB8716925D0 (en) Apparatus for treatment of spinal disorders
SG96694G (en) Treatment of skin disorders
GB2202442B (en) Treatment of periodontal disease
AU3813289A (en) Treatment of gastrointestinal disorders
GB8704532D0 (en) Treatment of froth
EP0300982A3 (en) Treatment of infertility
ZA884835B (en) Treatment of cerebral disorders
GB2195532B (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
ZA881828B (en) Preparation for treatment of skin disorders
GB8828185D0 (en) Improved medicine for treatment & prevention of stress & nervous disorders
GB8705285D0 (en) Treatment of psychiatric disorders
GB8725008D0 (en) Treatment of psychiatric disorders
ZA859768B (en) Treatment of gastrointestinal disorders
GB8618614D0 (en) Treatment of psychiatric disorders
GB8715317D0 (en) Treatment of medium
AU6596080A (en) Treatment of disorders of calcium metabolism
IE842027L (en) Treatment of skin disorders
GB8817446D0 (en) Treatment of various blood disorders
GB8326468D0 (en) Treatment of disorders of anatomy
IE900102L (en) Treatment of skin disorders
BG46628A1 (en) Means for treatment of artrose alterations
GB8509192D0 (en) Treatment of metabolic disorders